Sigrid Therapeutics: Funding, Investors & Team (Sep 2026)
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Sigrid Therapeutics has raised $14.4M across 3 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Jan 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sigrid Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Sigrid Therapeutics Funding Rounds
Sigrid Therapeutics raised $8.4M in an undisclosed round announced in Nov 2021.
1.2 years later, an undisclosed round of $1.0M was announced in Jan 2023.
3 years later, an undisclosed round of $5.0M was announced in Jan 2026.
Sigrid Therapeutics Founders and Leadership Team
Contact details for the Sigrid Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Sigrid Therapeutics Funding Compared to Other Biotechnology Startups
Sigrid Therapeutics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sigrid Therapeutics in Biotechnology and Stockholm
Companies Similar to Sigrid Therapeutics
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Sigrid Therapeutics Funding FAQs
What does Sigrid Therapeutics do?
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
How much funding has Sigrid Therapeutics raised?
Sigrid Therapeutics has raised $14.4M across 3 rounds on record. The most recent is an undisclosed round of $5.0M announced in Jan 2026.
When did Sigrid Therapeutics last raise funding?
Sigrid Therapeutics' most recent funding round on record is an undisclosed round of $5.0M, announced in Jan 2026.
Who is the CEO of Sigrid Therapeutics?
Sana Alajmovic is listed as CEO at Sigrid Therapeutics.
Where is Sigrid Therapeutics headquartered?
Sigrid Therapeutics is based in Stockholm, Stockholms Lan, Sweden.
How many employees does Sigrid Therapeutics have?
Sigrid Therapeutics is in the 11-50 employee band.
How does Sigrid Therapeutics' funding compare to other Biotechnology startups?
Sigrid Therapeutics' latest round of $5.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Sigrid Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sigrid Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.